Evolution of diagnostic certainty and PSP-predominance types in 187 pathologically confirmed PSP patients
Objective: To examine the evolution of diagnostic certainty and clinical predominance types as defined by the movement disorder society (MDS) criteria for the clinical diagnosis…Factors associated with freezing of gait in patients with Parkinson’s disease
Objective: The aim of this study was to estimate the prevalence of FOG (FOG), and to identify factors that independently contribute to FOG in patients…What strategies do Parkinson’s disease patients use for getting out of bed? Preliminary results from multisite wearable sensors analysis
Objective: To classify PD patients’ getting out of bed strategies using multisite wearable sensors. Background: Getting out of bed represents a major challenge for Parkinson’s…Predictors of health-related quality of life in Parkinson’s disease
Objective: To determine predictors of health-related quality of life (HRQoL) in patients with Parkinson’s disease (PD). Background: Determining the disease characteristics and symptoms associated with…Temporal Gait Parameters in Parkinson’s Disease: A Study Using PDlogger, A Quantitative Gait Measuring Device
Objective: Freezing of gait (FOG) is a disabling symptom in patients with Parkinson’s disease (PD). This study aims to investigate the differences in temporal gait…The international MDSGene initiative: Systematically exploring genotype-phenotype correlations of hereditary movement disorders
Objective: To explore phenotype-genotype relationships of familial movement disorders, the Movement Disorder Society Genetic Mutation Database (MDSGene) extracts, summarizes, and curates published data on the…Effective Tools for Mild Cognitive Impairment Level I Criteria of Movement Disorder Society: Utility of Screening Tests and Their Interconversion
Objective: Our primary aim was to test the utility of the universally accepted screening tests for detecting mild cognitive impairment (MCI) in patients with Parkinson’s…Alzheimer’s Disease Genetic Risk Variants Predict Cognitive Decline in Parkinson’s Disease
Objective: To evaluate the effect of genetic variants implicated in Alzheimer’s disease (AD) risk on cognitive decline in Parkinson’s disease (PD). Background: People with PD…Determining the effect of the HNMT, STK39 and NMD3 polymorphisms on the incidence of Parkinson’s disease, amyotrophic lateral sclerosis and multiple system atrophy in Chinese populations
Objective: To investigate associations between 3 variants (HNMT Thr105Ile, STK39 rs2390669, and NMD3 rs34016896) and PD, multiple system atrophy (MSA) as well as amyotrophic lateral…MicroRNAs as Biomarkers for Parkinson’s Disease
Objective: To identify potential biomarkers for Parkinson’s disease by evaluating miRNA in cerebrospinal fluid samples collected from PD and healthy control subjects. Background: The diagnosis…
- « Previous Page
- 1
- …
- 226
- 227
- 228
- 229
- 230
- …
- 405
- Next Page »